The Gastrointestinal Committee strives to:
Thirteenth TERMIS-AST-ISCT Joint Webinar featuring:
Watch the webinar
Dr. Rachele Ciccocioppo and Dr. Giuseppe Orlando have penned a letter, on the behalf of the ISCT Gastrointestinal Committee, to further encourage the inclusion of cell and gene therapy discussions and education in the gastrointestinal field in light of recent developments. ISCT members are kindly asked to please share this letter with their colleagues in the gastrointestinal field.
View the letter.
One of the ISCT Gastrointestinal Committee's main objectives is to increase awareness of cell and gene therapies in the field of the digestive system, and to promote the safe and effective use of these medicinal therapies worldwide. To help achieve these goals, the Committee conducts regular literature reviews, selects novel research to be featured alongside critical analyses developed by Committee members, and drafts reports on important events in the field.
View the report.
International Society for Cell & Gene Therapy Releases Position Statement on Diversity and Inclusiveness. View the full statement.
ISCT, alongside ASTCT, CIBMTR, EBMT, and FACT, issue a joint statement against racism. View the joint statement.
View All Committees
Amish Asthana, PhDWake Forest Institute for Regenerative MedicineWinston-Salem, United StatesRachele Ciccocioppo, MDUniversity of VeronaVerona, ItalyGianluca Carnevale, PhDUniversity of Modena and Reggio EmiliaModena, ItalyDamian García-Olmo, MD, PhDAutonomous University of MadridMadrid, Spain
Eleuterio Lombardo, PhDTakeda Madrid, Cell Therapy Technology CenterMadrid, Spain
Giuseppe Orlando, MD, PhDWake Forest UniversityWinston-Salem, United StatesShuji Terai, MD, PhDNiigata UniversityNiigata Japan